Gene · 64798
Papers1,775
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
101 to 120 of 1,775
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Multidimensional computational study to understand non-coding RNA interactions in breast cancer metastasis. | Sci Rep | 2023 | 37737288 | PubTator, text mining | PubMed |
BAMLET (Bovine α-lactalbumin made lethal to tumor cells) inhibits autophagy flux and induces apoptosis via down-regulation of protein kinase CK1α and attenuation of the AKT/p-ß-catenin (S552) pathway in RAS-mutated human colorectal HCT 116 cells. | Iran J Basic Med Sci | 2023 | 37736507 | PubTator, text mining | PubMed |
| Interaction of the AKT and β-catenin signalling pathways and the influence of photobiomodulation on cellular signalling proteins in diabetic wound healing. | J Biomed Sci | 2023 | 37735655 | PubTator, text mining | PubMed |
| The post-translational regulation of transcription factor EB (TFEB) in health and disease. | EMBO Rep | 2023 | 37728021 | PubTator, text mining | PubMed |
| Discovery of neddylation E2s inhibitors with therapeutic activity. | Oncogenesis | 2023 | 37717015 | PubTator, text mining | PubMed |
| Continuous sensing of nutrients and growth factors by the mTORC1-TFEB axis. | Elife | 2023 | 37698461 | PubTator, text mining | PubMed |
| Identifying prognostic markers in spatially heterogeneous breast cancer microenvironment. | J Transl Med | 2023 | 37644433 | PubTator, text mining | PubMed |
| Targeting EGFR/PI3K/AKT/mTOR Signaling in Hepatocellular Carcinoma. | Pharmaceutics | 2023 | 37631344 | PubTator, text mining | PubMed |
| Three-Year Follow-Up after Intrauterine mTOR Inhibitor Administration for Fetus with TSC-Associated Rhabdomyoma. | Int J Mol Sci | 2023 | 37629066 | PubTator, text mining | PubMed |
| Signaling Pathways Leading to mTOR Activation Downstream Cytokine Receptors in Lymphocytes in Health and Disease. | Int J Mol Sci | 2023 | 37628917 | PubTator, text mining | PubMed |
| The Developmental Implications of Muscle-Targeted Magnetic Mitohormesis: A Human Health and Longevity Perspective. | Bioengineering (Basel) | 2023 | 37627841 | PubTator, text mining | PubMed |
| Endometriosis-Associated Ovarian Carcinomas: How PI3K/AKT/mTOR Pathway Affects Their Pathogenesis. | Biomolecules | 2023 | 37627318 | PubTator, text mining | PubMed |
| An Update on Nucleolar Stress: The Transcriptional Control of Autophagy. | Cells | 2023 | 37626880 | PubTator, text mining | PubMed |
| Precision medicine advances in idiopathic pulmonary fibrosis. | EBioMedicine | 2023 | 37625268 | PubTator, text mining | PubMed |
| PI3K/AKT/mTOR signaling transduction pathway and targeted therapies in cancer. | Mol Cancer | 2023 | 37596643 | PubTator, text mining | PubMed |
| Implication of mTOR Signaling in NSCLC: Mechanisms and Therapeutic Perspectives. | Cells | 2023 | 37566093 | PubTator, text mining | PubMed |
| Identifying novel regulatory effects for clinically relevant genes through the study of the Greek population. | BMC Genomics | 2023 | 37543566 | PubTator, text mining | PubMed |
| Targeting NEDD8-activating enzyme for cancer therapy: developments, clinical trials, challenges and future research directions. | J Hematol Oncol | 2023 | 37525282 | PubTator, text mining | PubMed |
| Exploring the mTOR Signalling Pathway and Its Inhibitory Scope in Cancer. | Pharmaceuticals (Basel) | 2023 | 37513916 | PubTator, text mining | PubMed |
| mTOR Signaling Pathway and Gut Microbiota in Various Disorders: Mechanisms and Potential Drugs in Pharmacotherapy. | Int J Mol Sci | 2023 | 37511569 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/64798/papers?page=6